Veterinary Medicines

LAPICRINE SULFA

Authorised
  • Sulfadimidine sodium
  • Sulfaquinoxaline sodium
Download as PDF

Product identification

Medicine name:
LAPICRINE SULFA
Active substance:
  • Sulfadimidine sodium
  • Sulfaquinoxaline sodium
Target species:
  • Rabbit
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Sulfadimidine sodium
    19.80
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sulfaquinoxaline sodium
    6.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Rabbit
      • Meat and offal
        12
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01EQ30
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Huvepharma S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Huvepharma
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/7726041 9/1992
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."